72 related articles for article (PubMed ID: 24222525)
1. Contextual compound screening for improved therapeutic discovery.
Evensen L; Odlo K; Micklem DR; Littlewood-Evans A; Wood J; Kuzniewski C; Altmann KH; Hansen TV; Lorens JB
Chembiochem; 2013 Dec; 14(18):2512-8. PubMed ID: 24222525
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds.
Wolfe A; O'Clair B; Groppi VE; McEwen DP
J Biomol Screen; 2013 Dec; 18(10):1234-45. PubMed ID: 24019254
[TBL] [Abstract][Full Text] [Related]
3. Image-based high-throughput screening for inhibitors of angiogenesis.
Evensen L; Link W; Lorens JB
Methods Mol Biol; 2013; 931():139-51. PubMed ID: 23027002
[TBL] [Abstract][Full Text] [Related]
4. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
5. High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation.
Isherwood BJ; Walls RE; Roberts ME; Houslay TM; Brave SR; Barry ST; Carragher NO
J Biomol Screen; 2013 Dec; 18(10):1246-59. PubMed ID: 24108119
[TBL] [Abstract][Full Text] [Related]
6. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel angiogenesis inhibitors.
Sridhar J; Akula N; Sivanesan D; Narasimhan M; Rathinavelu A; Pattabiraman N
Bioorg Med Chem Lett; 2005 Sep; 15(18):4125-9. PubMed ID: 15993586
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.
Zhang L; Wang X; Feng J; Jia Y; Xu F; Xu W
Chem Biol Drug Des; 2012 Dec; 80(6):893-901. PubMed ID: 22913881
[TBL] [Abstract][Full Text] [Related]
9. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
11. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
12. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
13. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
14. Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase.
Rizvi SU; Siddiqui HL; Nisar M; Khan N; Khan I
Bioorg Med Chem Lett; 2012 Jan; 22(2):942-4. PubMed ID: 22200597
[TBL] [Abstract][Full Text] [Related]
15. Cassaine diterpene alkaloids from Erythrophleum fordii and their anti-angiogenic effect.
Hung TM; Cuong TD; Kim JA; Tae N; Lee JH; Min BS
Bioorg Med Chem Lett; 2014 Jan; 24(1):168-72. PubMed ID: 24332631
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
18. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.
Camus S; Quevedo C; Menéndez S; Paramonov I; Stouten PF; Janssen RA; Rueb S; He S; Snaar-Jagalska BE; Laricchia-Robbio L; Izpisua Belmonte JC
Oncogene; 2012 Sep; 31(39):4333-42. PubMed ID: 22179836
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
[TBL] [Abstract][Full Text] [Related]
20. Induced thyme product prevents VEGF-induced migration in human umbilical vein endothelial cells.
Krill D; Madden J; Huncik K; Moeller PD
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):275-81. PubMed ID: 21073864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
